Anti-Human CD262 Recombinant Antibody(Lexatumumab)
-
产品编号
YR1118
-
别名
科研级 Lexatumumab ( 来沙木单抗 ), Anti-CD262 Recombinant Antibody, Research Grade Lexatumumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Lexatumumab ( 来沙木单抗 ), Anti-CD262 Recombinant Antibody, Research Grade Lexatumumab |
| Catalog Number | YR1118 |
| Molecular Name | Lexatumumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG1 Lambda |
| Formulation | PBS, pH7.5 |
| Background | Lexatumumab (also known as ETR2-ST01) is an experimental agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2), intended for the treatment of cancer. HGS-ETR2 antibodies were generated by Human Genome Sciences through a collaboration with Cambridge Antibody Technology. Development was discontinued in 2015. |
| CAS Number | 845816-02-6 |
| Application | ELISA, IP, FCM, FuncS, Neut, IF |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | CD262[Homo sapiens] |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5号楼
-
销售微信
-
官方公众号
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
